Labs / Assays & in vitro testing
Gubra
Hørsholm, Denmark · gubra.dk
GLP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Gubra is a biotech company in Hørsholm, Denmark, with additional sites in Boston, United States, and Basel, Switzerland. It provides preclinical CRO services, drug discovery and development focused on peptide therapeutics, and venture creation and incubation. Its CRO work serves pharmaceutical and biotech companies worldwide.
Their website has a general contact form; we send your quote request through it.
What they offer
Preclinical contract research services
Preclinical studies to help pharmaceutical and biotech companies advance drug development pipelines.
Liver (MASH) studies
Validated MASH mouse models and related translational endpoints for efficacy and proof-of-concept work.
Obesity studies
Diet-induced obesity rodent models and efficacy studies with metabolic and body composition endpoints.
Kidney disease studies
Preclinical models for CKD, DKD and AKI with pharmacology, biomarkers, histology and 3D imaging.
Lung (IPF) studies
Bleomycin-induced IPF mouse models with pulmonary function, histopathology and transcriptomic readouts.
Diabetes studies
Preclinical diabetes assessment services using disease models and translational endpoints.
Women’s health studies
Preclinical studies in POI and PCOS models to assess novel compounds.
Muscle (sarcopenia) studies
Integrated muscle research platform for profiling drug candidates in sarcopenia-related work.
Non-rodent studies
PK, NGS and bioinformatics studies in miniature pigs.
3D imaging services
3D imaging to visualize and quantify effects in organs, including brain and whole kidney.
2D histology
Histology services for tissue analysis and endpoint quantification.
RNAseq services
RNA sequencing services to investigate molecular mode of action and transcriptomic profiles.
Peptide drug discovery
AI-assisted peptide discovery and optimization from target identification through candidate selection.
Drug development
Pharmaceutical development, preclinical development, IND-enabling activities and clinical development to clinical proof of concept.
Venture creation and incubation
Builds asset-centric biotech ventures around externally sourced opportunities.
What they work on
- Modalities
- Small molecule, Antibody, Peptide, Viral vector
- Species and models
- mouse, rat, miniature pig, C57BL/6J mice, DIO mouse, DIO rat, GAN DIO-MASH mouse, CDAA-HFD mouse, UUO mouse, ADI CKD mouse, uIRI mouse, 5/6 nephrectomy rat, and 2 more
- Assays and studies
- in vivo pharmacology, ex vivo assays, drug profiling, 2D histology, 3D whole brain imaging, whole organ imaging, energy expenditure, metabolic profiling, body composition, acute food intake monitoring, biomarker analysis, full metabolic assessment, and 3 more
- Instruments and platforms
- AI-based histology pipeline, whole body plethysmography, spirometry, 3D imaging technologies, GubraView
- Scale and capacity
- more than 300 scientists and experts
- Therapeutic areas
- Liver (MASH), Obesity, Kidney, Lung (IPF), CNS, Diabetes, Women’s Health, Muscle (Sarcopenia)
- Type
- CRDMO
- Sites
- Hørsholm, Denmark · Boston, United States · Basel, Switzerland
- Team
- more than 300 scientists and experts
- Quality
- AALAC-I accreditation (animal research program) · Quality management system (data integrity and controlled documentation)
- Serves
- worldwide, global partners
- Address
- 2 Stonecutter Street) or via Webcast. Presentaion (PDF) Webcast video London and online In
- Founded
- 2020
Similar labs. EyeCRO, Sparx BIO, Syd Labs, Allumiqs
Found in a contract services directory. Listing built from gubra.dk. Work here? Claim this listing.